Journal of the Korean Academy of Child and Adolescent Psychiatry : eISSN 2233-9183 / pISSN 1225-729X

Table. 1.

Table. 1.

Demographic and anthropometric characteristics

Drug-naive ADHD (n=64) MPH-treated ADHD* (n=39) Control (n=112) p-value
Sex 0.25
Boy 41 (64.1) 31 (79.5) 79 (70.5)
Girl 23 (35.9) 8 (20.5) 33 (29.5)
Age, years
Boy 8.81±1.52 9.48±1.44 9.20±1.65 0.14
Girl 9.22±1.51 9.89±1.45 9.36±1.44 0.54
Height†, cm
Boy 0.38±0.85 0.66±1.07 0.38±0.88 0.23
Girl 0.62±1.04 0.31±0.78 0.68±0.78 0.57
Weight, kg
Boy 0.10±1.02 0.21±1.21 0.25±1.05 0.77
Girl 0.42±0.88 0.09±1.30 0.53±0.99 0.53
BMI†, kg/m2
Boy -0.18±1.43 0.03±1.22 0.19±1.09 0.29
Girl -0.33±1.16 0.51±1.14 0.78±0.98 0.14

Variables are presented as n (%) or mean±standard deviation. *mean duration of treatment: 1.79 (±1.11) years; mean MPH dose: 1.02 (±0.39) mg/kg, age- and sex-corrected standard scores (z-scores). ADHD: attention-deficit/hyperactivity disorder, BMI: body mass index, MPH: methylphenidate

J Korean Acad Child Adolesc Psychiatry 2020;31:154-60 https://doi.org/10.5765/jkacap.200014
© 2020 J Korean Acad Child Adolesc Psychiatry